0000914190-15-000295.txt : 20150811 0000914190-15-000295.hdr.sgml : 20150811 20150811164046 ACCESSION NUMBER: 0000914190-15-000295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150807 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERONNEAU MARCEL CENTRAL INDEX KEY: 0001213074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 151044397 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE N.E. CITY: MINNEAPOLIS STATE: MN ZIP: 55413 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-07 0000842023 BIO-TECHNE Corp TECH 0001213074 VERONNEAU MARCEL 614 MCKINLEY PLACE N.E. MINNEAPOLIS MN 55413 0 1 0 0 SVP - Clinical Controls Common Stock 34913 D Common Stock 6827 I by Stock Bonus Plan Stock Option (Right to Buy) 62.46 2016-07-23 Common Stock 494 494 D Stock Option (Right to Buy) 66.25 2017-04-29 Common Stock 10000 10000 D Stock Option (Right to Buy) 58.40 2017-07-29 Common Stock 1281 1281 D Stock Option (Right to Buy) 76.15 2018-07-27 Common Stock 20000 20000 D Stock Option (Right to Buy) 76.15 2018-08-27 Common Stock 1129 1129 D Stock Option (Right to Buy) 74.05 2019-07-26 Common Stock 1097 1097 D Stock Option (Right to Buy) 76.02 2020-07-31 Common Stock 15000 15000 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 15000 15000 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 7500 0 A 2022-08-07 Common Stock 7500 7500 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 3750 0 A 2022-08-07 Common Stock 3750 3750 D Restricted Stock Units 2015-08-07 4 A 0 600 0 A Common Stock 600 600 D Fully exercisable. Vests 3,750 shares on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17. Vests 3,750 shares on each of 8/12/15, 8/12/16, 8/12/17, and 8/12/18. Vests 1,875 shares on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. /s/ Elizabeth M. Dunshee as Attorney-in-Fact for Marcel Veronneau pursuant to Power of Attorney filed herewith. 2015-08-11 EX-24 2 veronneaupoa.htm VERONNEAU POWER OF ATTORNEY
POWER OF ATTORNEY



 The undersigned hereby constitutes and appoints Brenda S. Furlow,

James Hippel, Melodie R. Rose and Elizabeth M. Dunshee, or either of

them acting alone, the undersigned's true and lawful attorneys-in-fact

and agent with full power of substitution and resubstitution, for the

undersigned and in the undersigned's name, place and stead, in any and

all capacities, to sign any or all Forms 3, Forms 4 and Forms 5

relating to beneficial ownership of securities of Techne Corporation

(the "Issuer"), to file the same, with all exhibits thereto and other

documents in connection therewith, with the Securities and Exchange

Commission and to deliver a copy of the same to the Issuer, granting

unto said attorney-in-fact and agent full power and authority to do and

perform each and every act and thing requisite and necessary to be done

in and about the premises, as fully to all intents and purposes as the

undersigned might or could do in person, hereby ratifying and

confirming all said attorneys-in-fact and agent, or his substitute or

substitutes, may lawfully do or cause to be done by virtue thereof.

The undersigned acknowledges that the foregoing attorney-in-fact, in

serving in such capacity at the request of the undersigned, is not

assuming any of the undersigned's responsibilities to comply with

Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney shall remain in effect until such time as

the undersigned is no longer subject to the provisions of Section 16 of

the Securities Exchange Act of 1934 with respect to securities of the

Issuer.



 IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 30th day of October 2014.



                  /s/ Marcel Veronneau